ASH: Anti-CD19 CAR T-cell Tx beneficial in B-cell lymphomas – Medical Xpress
Medical Xpress |
ASH: Anti-CD19 CAR T-cell Tx beneficial in B-cell lymphomas
Medical Xpress Sattva S. Neelapu, M.D., from the University of Texas MD Anderson Cancer Center in Houston, and colleagues enrolled 111 patients with diffuse large B-cell lymphoma, primary mediastinal B-cell lymphoma, or transformed follicular lymphoma with refractory … |
